EUVIMEDEUVIMED entdecken
Crossref

Genotype-Guided Antiplatelet Therapy After Coronary Intervention in Patients With High Bleeding Risk ― Never Judge a Book by Its Cover ―

Raisuke Iijima

Circulation Journal · 2023

DOI: 10.1253/circj.cj-23-0170 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation Journal, 2023. Verfasst von Raisuke Iijima. Beteiligte Einrichtung: Division of Cardiovascular Medicine, Ohashi Medical Center, Toho University. Hauptthemen laut MEDLINE: Percutaneous Coronary Intervention, Acute Coronary Syndrome. Die Arbeit nennt 9 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Percutaneous Coronary InterventionAcute Coronary SyndromeHumansPlatelet Aggregation InhibitorsHemorrhageClopidogrelHeartGenotypeTreatment OutcomeCytochrome P-450 CYP2C19

Substanzen

Platelet Aggregation InhibitorsClopidogrelCytochrome P-450 CYP2C19

Autor:innen und Institutionen

  • Division of Cardiovascular Medicine, Ohashi Medical Center, Toho University.

Zitieren

APA

Iijima, R. (2023). Genotype-Guided Antiplatelet Therapy After Coronary Intervention in Patients With High Bleeding Risk ― Never Judge a Book by Its Cover ―. Circulation Journal. https://doi.org/10.1253/circj.cj-23-0170

Vancouver

Iijima R. Genotype-Guided Antiplatelet Therapy After Coronary Intervention in Patients With High Bleeding Risk ― Never Judge a Book by Its Cover ―. Circulation Journal. 2023. doi:10.1253/circj.cj-23-0170

BibTeX
@article{Iijima2023,
  author = {Iijima, Raisuke},
  title = {Genotype-Guided Antiplatelet Therapy After Coronary Intervention in Patients With High Bleeding Risk ― Never Judge a Book by Its Cover ―},
  journal = {Circulation Journal},
  year = {2023},
  doi = {10.1253/circj.cj-23-0170}
}
Kostenlos starten →